[ET Net News Agency, 25 August 2021] Livzon Pharmaceutical Group Inc. (01513) said its
net profit attributable to shareholders of the company was RMB1.06 billion for the six
months ended 30 June 2021, a year-on-year increase of 5.75%. Basic earnings per share were
RMB1.14. No dividend will be distributed.
Operating income was RMB6.24 billion, a year-on-year increase of 22.38%. (RC)